As we reflect upon 2018, we recognize that SARC is the collective effort of the sarcoma community. We are very grateful for the generous gifts of time and money that have helped to further the mission of SARC to improve outcomes for patients with sarcoma.
It is through these collaborative efforts that we make progress. In 2018 we have completed trials and correlative analyses to better understand who may or may not benefit from a therapy we are testing. We have presented at national meetings and published the results so they are available to the entire community.
It is with your continued help that we will make progress in prevention, diagnosis and treatment of sarcoma. We look forward to a productive 2019.
Denise Reinke, President and CEO